Suicide Risk in Children and Adolescents: Screening

  1. More randomized controlled trials are needed on the benefits and harms of screening for suicide risk in children and adolescents in primary care settings compared with no screening or usual care.
  2. More information is needed on the performance characteristics of screening tests for suicide risk.
  3. Treatment studies are needed in populations with screen-detected suicide risk, in all age groups.
  4. Evidence on screening and treatment is lacking in populations defined by sex, race and ethnicity, sexual orientation, and gender identity, such as Native American/Alaska Native youth (who are at increased risk for suicide). More research is needed in these populations.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for suicide risk in children (11 years and younger) and adolescents (aged 12 to 18 years).

Suicide Risk in Children and Adolescents: Screening Read full statement